Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,93 USD | +4,89% | +4,32% | +36,88% |
Omzet 2024 * | 250K 234K | Omzet 2025 * | 250K 234K | Marktkapitalisatie | 323 mln. 302 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -133 mln. -124 mln. | Nettowinst (verlies) 2025 * | -151 mln. -141 mln. | EV/omzet 2024 * | 1.065 x |
Nettoliquiditeiten 2024 * | 56,8 mln. 53,12 mln. | Nettoliquiditeiten 2025 * | 168 mln. 157 mln. | EV/omzet 2025 * | 619 x |
K/w-verhouding 2024 * |
-2,49
x | K/w-verhouding 2025 * |
-2,51
x | Werknemers | 83 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,01% |
Recentste transcriptie over Atai Life Sciences N.V.
1 dag | +4,89% | ||
1 week | +4,32% | ||
Lopende maand | -2,03% | ||
1 maand | +11,56% | ||
3 maanden | +12,21% | ||
6 maanden | +69,30% | ||
Lopend jaar | +36,88% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01-06-18 |
Srinivas Rao
FOU | Founder | 55 | 01-06-18 |
Anne Johnson
DFI | Director of Finance/CFO | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01-01-21 |
Founder | 46 | 01-06-18 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.84% | 1 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,93 | +4,89% | 875 019 |
25-04-24 | 1,84 | -1,60% | 822 238 |
24-04-24 | 1,87 | -5,08% | 842 720 |
23-04-24 | 1,97 | +5,35% | 1 200 332 |
22-04-24 | 1,87 | +1,08% | 1 049 274 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+36,88% | 308 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |